1. Home
  2. NVCR vs STAA Comparison

NVCR vs STAA Comparison

Compare NVCR & STAA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NVCR
  • STAA
  • Stock Information
  • Founded
  • NVCR 2000
  • STAA 1982
  • Country
  • NVCR Switzerland
  • STAA United States
  • Employees
  • NVCR N/A
  • STAA N/A
  • Industry
  • NVCR Medical/Dental Instruments
  • STAA Ophthalmic Goods
  • Sector
  • NVCR Health Care
  • STAA Health Care
  • Exchange
  • NVCR Nasdaq
  • STAA Nasdaq
  • Market Cap
  • NVCR 1.9B
  • STAA 850.9M
  • IPO Year
  • NVCR 2015
  • STAA N/A
  • Fundamental
  • Price
  • NVCR $17.71
  • STAA $17.86
  • Analyst Decision
  • NVCR Buy
  • STAA Hold
  • Analyst Count
  • NVCR 6
  • STAA 8
  • Target Price
  • NVCR $32.83
  • STAA $27.17
  • AVG Volume (30 Days)
  • NVCR 1.6M
  • STAA 814.8K
  • Earning Date
  • NVCR 07-24-2025
  • STAA 08-06-2025
  • Dividend Yield
  • NVCR N/A
  • STAA N/A
  • EPS Growth
  • NVCR N/A
  • STAA N/A
  • EPS
  • NVCR N/A
  • STAA N/A
  • Revenue
  • NVCR $621,711,000.00
  • STAA $279,134,000.00
  • Revenue This Year
  • NVCR $5.56
  • STAA N/A
  • Revenue Next Year
  • NVCR $9.19
  • STAA $29.34
  • P/E Ratio
  • NVCR N/A
  • STAA N/A
  • Revenue Growth
  • NVCR 18.27
  • STAA N/A
  • 52 Week Low
  • NVCR $14.17
  • STAA $13.50
  • 52 Week High
  • NVCR $34.13
  • STAA $49.86
  • Technical
  • Relative Strength Index (RSI)
  • NVCR 51.32
  • STAA 55.08
  • Support Level
  • NVCR $17.53
  • STAA $16.40
  • Resistance Level
  • NVCR $18.70
  • STAA $17.24
  • Average True Range (ATR)
  • NVCR 0.72
  • STAA 0.66
  • MACD
  • NVCR 0.09
  • STAA 0.13
  • Stochastic Oscillator
  • NVCR 60.56
  • STAA 91.76

About NVCR NovoCure Limited

NovoCure Ltd is an oncology company with a propreitary platform technology in United States. Its business involves the development, manufacture and commercialization of Tumor Treating Fields (TTFields) devices, including Optune Gio and Optune Lua, for the treatment of solid tumor cancers. Its pipeline consists of Trident, Lunar-2, Panova-3, Metis and other products and technologies for the treatment of Glioblastoma, Non-smell cell lung cancer and Pancreatic cancer. Geographically, the company derives majority of its revenue from the United States and rest from Germany, Japan and other markets.

About STAA STAAR Surgical Company

Staar Surgical Co is a manufacturer of lenses. It designs, develops, manufactures, and sells implantable lenses for the eye and delivery systems used to deliver the lenses into the eye. The company also makes lenses that are used in surgery to treat cataracts. The company offers two types of products: Implantable Collamer lenses (ICL) and intraocular lens (IOL). The ICLs are used in refractive surgery and IOLs are used in cataract surgery. The majority of its sales are generated from the ophthalmic surgical product segment.

Share on Social Networks: